Association between serum adiponectin levels and arteriolosclerosis in IgA nephropathy patients

Internal Medicine

Volumn 46, Issue 8, 2007, Pages 453-460

  Takahashi, Masaki ^a   Otsubo, Shigeru ^a   Uchida, Keiko ^a   Yumura, Wako ^a   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic glomerular nephritis; Chronic kidney disease; Creatinine clearance; Glomerulonephritis; Kidney

Indexed keywords

ADIPONECTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CANDESARTAN HEXETIL; CHOLESTEROL; CREATININE; LOSARTAN; PROTEIN; TRIACYLGLYCEROL; VALSARTAN;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC GLOMERULONEPHRITIS; CORRELATION ANALYSIS; CREATININE CLEARANCE; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; MULTIPLE REGRESSION; NEPHROSCLEROSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEINURIA; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADULT; ARTERIOLOSCLEROSIS; BIOLOGICAL MARKERS; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY; MALE; MIDDLE AGED;

EID: 34247402512     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6332     Document Type: Article

References (24)

1. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83, 1999.
2. Aso Y, Yamamoto R, Wakabayashi S, et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 55: 1954-1960, 2006.
3. Kojima S, Funahashi T, Maruyoshi H, et al. Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma. Thromb Research 115: 483-490, 2005.
4. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 102: 1296-1301, 2000.
5. Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103: 1057-1063, 2001.
6. Arita Y, Kihara S, Ouchi N, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common post-receptor signal in vascular smooth muscle cell. Circulation 105: 2893-2898, 2002.
7. Cavusoglu E, Ruwende C, Chopra V, et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 27: 2300-2309, 2006.
8. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599, 2000.
9. Mallamaci F, Zoccali C, Cuzzola F, et al. Adiponectin in essential hypertension. J Nephrol 15: 507-511, 2002.
10. Saraheimo M, Forsblom C, Fagerudd J, et al, Groop PH; FinnDiane Study Group. Serum Adiponectin is increased in Type 1 diabetic Patients with Nephropathy. Diabetes Care 28: 1410-1414, 2005.
11. Isobe T, Saitoh S, Takagi S, et al. Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol 153: 91-98, 2005.
12. Zoccali C. Mallamaci F, Panuccio V, et al. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int 63: S98-S102, 2003.
13. Schalkwijk CG, Chaturvedi N, Schram MT, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group. Adiponectin is inversely associated with renal function in type 1 diabetic patients. J Clin Endocrinol Metab 91: 129-135, 2006.
14. Gamble CN. The pathogenesis of hyaline arteriolosclerosis. Am J Pathol 122: 410-412, 1986.
15. Moritz AR, Oldt ME. Arteriolar sclerosis in hypertensive and non-hypertensive individuals. Am J Pathol 13: 679-686, 1937.
16. Mallamaci F, Zoccali C, Cuzzola F. Adiponectin in essential hypertension. J Nephrol 15: 507-511, 2002.
17. Looker HC, Krakoff J, Funahashi T, et al. Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 89: 4010-4017, 2004.
18. Shen YY, Charlesworth JA, Kelly JJ, Loi KW, Peake PW. Upregulation of adiponectin, its isoforms and receptors in end-stage kidney disease. Nephrol Dial Transplant 22: 171-178, 2007.
19. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107: 671-674, 2003.
20. Furuhashi M, Ura N, Higashiura K, et al. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 42: 76-81, 2003.
21. Aso Y, Yamamoto R, Wakabayashi S, et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 55: 1954-1960, 2006.
22. Hill GS, Heudes D, Bariety J. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation. Kidney Int 63: 1027-1036, 2003.
23. Lee HS, Spargo BH. Significance of renal hyaline arteriolosclerosis in focal segmental glomerulosclerosis. Nephron 41: 86-93, 1986.
24. Olson JL. Hyaline arteriolosclerosis: new meaning for an old lesion. Kidney Int 63: 1162-1163, 2003.